VESPERPDA10mg / vialLYOPHILIZEDRESEARCH USE ONLY
VESPERPDA10mg / vialLYOPHILIZEDRESEARCH USE ONLY
VESPERPDA10mg / vialLYOPHILIZEDRESEARCH USE ONLY
VESPERPDA10mg / vialLYOPHILIZEDRESEARCH USE ONLY
≥99.5% PURITY·HPLC VERIFIED·MASS SPEC CONFIRMED·USA SYNTHESIZED

PDA

Pentadeca Arginate

$78.00

· per vial
≥99.5%HPLCRUO
IN STOCK · SHIPS TODAY124 of batch remaining
Batch
VR-26-04-PDA-01
Sealed
Apr 21, 2026
Sequence
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (arginate salt)
Molecular Weight
≈1635 g/mol
CAS Number
Not formally assigned
Appearance
White lyophilized powder
Storage
−20°C, protected from light

Research Areas

  • · Storage-stable BPC-157 analogue research
  • · Tendon and connective-tissue models
  • · Gastrointestinal repair studies
Quantity
1
⚠ For research use only. Not for human consumption.
Not approved by the FDA. Not for diagnostic use.

Pentadeca Arginate (PDA) is a stabilised arginate-salt analogue of the BPC-157 pentadecapeptide sequence. Studied in preclinical literature as a more storage-stable alternative for tissue-repair research models.